Patent · US Active

Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

US9133210B2 · kind B2 · utility

4Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2014
Grant dateSep 15, 2015
Priority date
Expiry dateAug 5, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/6561
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses compounds according to Formula I:wherein R1 is as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment cystic fibrosis by administering a compound of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.